National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 1411917

History of Changes from the VAERS Wayback Machine

First Appeared on 7/23/2021

VAERS ID: 1411917
VAERS Form:2
Vaccin­ation / Manu­facturer Lot / Dose Site / Route

Administered by: Other      Purchased by: ??
Symptoms: Anaphylactic reaction, Body temperature, Choking sensation, Dysphagia, Oxygen saturation, Vital signs measurement

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: Rhinitis allergic
Preexisting Conditions:
Diagnostic Lab Data: Test Date: 20210603; Test Name: body temperature; Result Unstructured Data: Test Result:36.4 Centigrade; Comments: before vaccination; Test Date: 20210603; Test Name: oxygen saturation; Test Result: 99 %; Test Date: 20210603; Test Name: vital; Result Unstructured Data: Test Result:Normal
CDC 'Split Type': JPPFIZER INC2021655925

Write-up: slight Anaphylaxis; swallowing difficult; Pharynx strangled sensation of; This is a spontaneous report from a contactable physician received from the Regulatory Authority (RA). Regulatory authority report number is v21111778. The patient was 51-year and 9-month female. Body temperature before vaccination was 36.4 degrees Centigrade. The patient had relevant medical history of rhinitis allergic and was receiving medical treatment by oral administration. On 03Jun2021 at 10:15 (the day of vaccination), the patient received the second dose of bnt162b2 (COMIRNATY, Lot number EY5420 and Expiration date 31Aug2021) at the age of 51-year-old. On 03Jun2021, the results of the events were recovered. The details of event were as follows: On 03Jun2021 (the day of vaccination), 30 minutes after the vaccination, the patient experienced swallowing difficult and pharynx strangled sensations of, and the symptoms became progressively stronger. No breathing difficulty, vital signs normal including oxygen saturation (99%). But the symptoms were still ongoing, so the patient received BOSMIN 0.15mg intramuscular injection. After the injection, the symptoms were clearly improved. The reporter classified the event as non-serious and assessed the causality between the event and the vaccines as related. The reporter commented as follows: it was considered as slight anaphylaxis.

New Search

Link To This Search Result:

Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166